Croda expands biopharma capabilities through strategic partnership

9 December 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announced a strategic supply partnership with Amino GmbH (“Amino”), a leading manufacturer of pharmaceutical-grade amino acids, aimed at strengthening the global availability of high purity amino acids for pharmaceutical formulation and biomanufacturing.

Amino acids are the basic building blocks of proteins, essential molecules that make up cells, enzymes, and many biological structures. In pharmaceuticals, amino acids can be used as excipients to formulate biologic drugs and serve as ingredients in the manufacturing of biologicals, such as monoclonal antibodies.

Thomas Riermeier, President, Life Sciences, says: “Our collaboration marks an exciting step forward in expanding the high-quality ingredients available to biopharma developers. By working together, we’re helping customers increase the efficiency of their processes and advance the therapies that will shape the future of patient care.”

Combining Croda’s deep expertise in smart science and global market reach, with Amino’s advanced capabilities in precision manufacturing of amino acids will enable Croda to deliver even more innovative, high-quality and sustainable solutions that help customers accelerate their product development and achieve greater efficiency.

"This partnership reflects Croda’s strategy, to strengthen our ability to support customers in the fast-evolving biopharma landscape” said Katie Dec, Global Business Director, Croda Pharma Insights. "Amino’s strong reputation and expertise make them an ideal partner as we continue to deliver high-quality, reliable materials needed to bring new therapies to market.” We are excited to launch our new range of BioXPro™ high-purity histidine and arginine amino acids in January. These products will provide the purity, consistency, and batch-to-batch reproducibility that our customers value.

“The partnership with Croda is both a milestone and a catalyst for Amino’s ambitions in biopharmaceuticals. The combination of Croda’s market reach and our high-purity amino acid production expertise forms a partnership dedicated to meeting specific customer demands,” states Lutz Thomas, Managing Director of Amino GmbH.

This reinforces Croda’s commitment to supplying the highest purity ingredients for pharmaceutical formulation and biomanufacturing and follows on from the recent launches of Virodex™ for viral inactivation and cell lysis, and Super Refined™ Poloxamer 188 as a shear protectant in cell culture media.

To learn more about our latest innovations, including Super Refined Poloxamer 188, please visit Croda Pharma. Comprehensive product information for the BioXPro™ range will be released in January 2026.

ENDS 

 

For media enquiries, please contact: 

Mariana Wood, Croda Press Office 
+44 7780 987 136 
media.enquiries@croda.com 

Notes to Editors 

About Croda  

Croda is a specialty chemicals company that creates high performance ingredients and solutions principally for Consumer Care and Life Sciences markets. Established 100 years ago in 1925 and headquartered in the UK, Croda is a FTSE 100 company with over 5,800 employees across 94 locations in 36 countries. Revenues in 2024 were £1.6bn.  

As the name behind some of the world’s most successful brands, we combine our knowledge, passion and entrepreneurial spirit to develop and supply innovative ingredients relied on by industries and consumers around the world. Our smart science is found in products that touch our lives every day from sun protection to life-saving pharmaceuticals and formulations that enhance crop yields.  

With a shared Purpose to use Smart science to improve lives™, and with around two thirds of its organic raw materials already from bio-based sources, Croda has committed to be the most sustainable supplier of innovative ingredients, becoming Climate, Land and People Positive by 2030 while providing solutions to some of the world’s biggest challenges.  

To find out more about Croda visit: www.croda.com
 

About Croda Pharma 
Croda’s Pharma business is a leading partner in the development of excipients and the supply of high purity materials for pharmaceutical formulations and is committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms. 

To find out more about Croda Pharma visit: www.crodapharma.com


About Amino
Amino GmbH based in Frellstedt, Germany is a manufacturer of high-quality amino acids and related substances focused on pharmaceutical and nutritional applications. 

The business portfolio is completed by our innovation platform AminoVation as well as amino acid premixes aunder the AMixCo brand.


To find out more about Amino GmbH visit: www.amino.de